Objective: To determine postnatal electrocardiographic abnormalities in fetuses with echogenic cardiac foci (ECF) and no congenital heart disease (CHD).
Introduction
Echogenic cardiac foci (ECF) are microcalcifications in the vicinity of papillary muscles, chordae tendineae or atrioventricular valves, detected in 3.7 to 5.6% of fetuses undergoing ultrasound examination. 1, 2 Despite no clear association with congenital heart disease (CHD), some functional cardiac abnormalities have been reported. [1] [2] [3] [4] [5] There is paucity of data, however, in respect to postnatal electrocardiographic abnormalities in fetuses with ECF, and whether they exert any arrhythmogenic potential.
We sought to determine the electrocardiographic significance in infants born with ECF and no CHD, and followed prospectively up to 2 years of age.
Methods
We prospectively included all pregnant women undergoing fetal echocardiography (echo) secondary to ECF detected by the initial fetal ultrasound, between January 2006 and December 2009. Fetuses with ECF and CHD were excluded. Fetal echo was performed by a single operator and followed guidelines of the International Society of Ultrasound in Obstetrics and Gynecology. 6 After birth, infants underwent 1 to 4 echo's, one 12-lead electrocardiogram (ECG), and one 24-h ambulatory ECG (Holter), at 0 to 24 months of age. Two pediatric cardiologists blinded to the results of the fetal echo interpreted the studies. Several ECG and Holter measurements were obtained (Table 2) , as well as any recorded arrhythmia. Technical details of the studies performed are included in Supplementary Table 1 . Fetal and postnatal cardiac dimensions, and ECG and Holter measurements were compared with the published reference values for age. [7] [8] [9] [10] [11] [12] [13] Parents were informed about the aim of the study. Appointments were scheduled within 3 months after birth, and every 6 to 12 months afterwards through 24 months of age. Our institution's Ethics Committee approved the study design.
Statistical analysis was performed using SPSS version 17 (Tawam Hospital, Institutional License, Chicago, IL, USA). Categorical data were compared using the w 2 -analysis, and Fisher's exact test. Numerical data were compared using paired and unpaired sample t-test where appropriate. A two-tailed P-value <0.05 was considered significant. ECG and Holter measurements were standardized by creating Z-scores relative to the general population (matched for age): Z-score ¼ (mean of observed valueÀmean in general population)/s.d. in general population. Normal distribution was assessed before standardization.
Results
Between January 2006 and December 2009, 4960 pregnant women were referred to our Fetal Medicine Unit, of which 1137 women carrying 1268 fetuses underwent fetal echo. ECF was diagnosed in 63/1268 fetuses (5%), of which 22 were excluded. Five fetuses were excluded because of fetal CHD, and 17 were excluded because of planned delivery at other institutions where postnatal follow-up would not have been possible. The remaining 41 singleton fetuses were included in this study. Fetal characteristics and results of fetal echo are shown in Supplementary Table 2 . The number of ECF ranged from 1 to 6 (mean of 2 foci per fetus), and they all measured 2 to 4 Â 3 to 4 mm in diameter. Three fetuses (7.3%) had renal anomalies confirmed postnatally (Supplementary Table 2 ).
After birth, infants (55% males) underwent one echo examination within 3 months, and every 6 to 12 months afterwards throughout follow-up (Table 1) . Patients were followed for a mean (s.d.) of 8.1 (6.2) months (range 1 to 24 months). Location of ECF in fetal and postnatal echo's are shown in Supplementary Table 2  and Table 1 . ECF disappeared in 10 infants (24.4%) by 24 months of age, and minor cardiac lesions (other than patent foramen ovale) were detected in seven infants (17.1%), and resolved on follow-up (Table 1 ). Karyotyping and/or clinical examination were normal in all infants.
ECGs and Holters were obtained at a mean of 1 (2.1) and 1.3 (3.1) months, respectively (range 0 to 7 and 0 to 19 months, respectively). Two infants had their ECGs at 6 and 7 months, and one infant had his Holter at 19 months, resulting in such wide ranges. ECG showed normal sinus rhythm in all infants, and no clinically significant abnormalities. Minor abnormalities were detected in 15 infants (36.6%), including right axis deviation in 8 (19.5%), biatrial enlargement in 1 (2.4%), and left, right or biventricular hypertrophy in 6 infants (14.6%). These abnormalities did not correlate with the echo findings. A Z-score >2 for some ECG measurements was observed in 18 infants (43.9%) ( Table 2 ). Holters showed normal heart rate (HR) and variability, and normal average QT interval corrected for HR (QTc) in all infants, without significant arrhythmia. Two infants (4.9%) had a Z-score >2 for maximum HR, and five (12.2%) had isolated premature atrial or ventricular contractions ranging from 0.3 to 3% of the total recorded beats ( Table 2) .
There was no significant difference between infants with persistent or resolved ECF in the fetal characteristics, postnatal echo's, and ECG and Holter measurements (Supplementary Table 3 ).
Discussion
We excluded fetuses with CHD, but postnatal echo showed minor lesions in three and trace tricuspid regurgitation in four infants (Table 1) . These abnormalities are difficult to detect antenatally, and have no hemodynamic significance postnatally. Fetal echo in our study was performed at a mean gestation of 25.6 weeks, which is later than other studies. 4,14 -16 This is explained by late referral to our fetal echo laboratory and late booking. In addition, abortion is not permitted in our country, and fetal echo is generally done after 20 weeks.
Our study looked at several electrocardiographic measurements in infants born with ECF and structurally normal hearts. To our knowledge, this is the first study to look at ECG and Holter recordings in this population. Clinically insignificant functional cardiac abnormalities were previously reported by studies utilizing fetal or postnatal echo parameters, but electrocardiographic data are lacking. 3, 5, 15, 17 Several ECG and Holter abnormalities were detected in 25 (61%) and 7 (17.1%) infants in our study, respectively. These abnormalities were mostly false-positive findings, which did neither correlate with the normal echo's these infants had, nor their postnatal follow-up. Most of the recordings were obtained within the first month of life, when the heart exerts electrical immaturity and myocardial instability. Motion artefacts and non-specific T-wave abnormalities are common in younger infants resulting in false-positive results. 10, 11, 13, 18 Measurements which depend on the morphology of T-waves (such as QTc) are more prone to errors, particularly if such measurements are not averaged over time. This is evident by having prolonged QTc in seven infants by ECG, but not by Holter (Table 2) . Similarly, right axis deviation and ventricular hypertrophy on the surface ECG are common in neonates. 7, 11 Two infants had Z-scores >2 for the recorded maximum HR by Holter, but their HR variability was normal ( Table 2 ). None of the infants had any significant arrhythmia except for isolated premature atrial and ventricular contractions, both of which occur normally in 15 to 30% of infants in this age group. 9 Therefore, neither ECG nor Holter showed clinically significant abnormalities.
ECF resolve in up to 40% of postnatal echo's especially when located in the right ventricle. 14, 19 These microcalcifications indicate normal variation in the cardiac development. Further growth and maturation of cardiac structures after birth result in regression of these calcifications and resolution of ECF in infancy or childhood. 2, [20] [21] [22] We found that ECF disappeared in nearly onequarter of infants by 24 months of age, and there was no difference between infants with persistent or resolved ECF when various ECG and Holter measurements were compared (Supplementary Table  3 ). This supports the lack of association of ECF with the electrocardiographic abnormalities in our study, which can otherwise be found in normal infants.
Conclusion
Isolated ECF are common in the normal euploid fetus. They impose no adverse electrocardiographic outcome even if they persist after birth.
Limitations
This is a prospective study involving a relatively small number of infants followed for a short period of time. ECGs and Holters were performed only once during the study, which may have increased the false positive results. However, the study may add additional evidence to the lack of clinical significance of isolated fetal ECF postnatally.
